A 3D-Printed Brain Implant Cools Seizure Activity in Rats

One printed device, three jobs

Researchers at the University of Sheffield and TU Dresden have printed a brain implant that records electrical activity and cools a patch of cortex, all as one continuous structure, according to a Tech Times report on October 29. The work was published in Advanced Science in September 2026. The aim is an alternative approach for drug-resistant focal epilepsy, which affects roughly 15 million people worldwide per the report.

How it is built

Using direct ink writing, a form of extrusion 3D printing, the team deposited medical-grade silicone with graphite-based conductive traces. The finished device measures 10 by 10 by 3 millimeters. The bottom layer holds recording electrodes, the middle layer a Peltier cooler that moves heat away from the brain surface, and the top layer a water channel carrying heat off. Silicone is far softer than traditional rigid implant materials, which may reduce irritation.

The results

In rats given a chemical that triggers focal seizures, cooling the cortex to 18 degrees C produced about a 70% drop in local field potential power. Surprisingly, cooling to 15 degrees C was less effective, and the researchers have not fully explained why; the report notes cold-sensitive ion channels as one possible factor.

Long road to patients

This was an acute rodent experiment, not a chronic human trial, and field potential power is not the same as seizure frequency. The current external driver draws about 2.6 watts, far above what implants normally use, so miniaturizing power electronics is the main hurdle. The report says human use is likely a decade or more away.

Practical takeaways

  • Treat this as early lab research, not a treatment option.
  • Single-piece printing could simplify future multi-function neural implants.
  • Power consumption is the key engineering milestone to watch.

Bottom line

The Sheffield and Dresden implant shows how printing can merge sensing and cooling in a soft package. Its seizure result is promising but strictly preclinical.

Sources